PARATHYROID HORMONE (PTH), 1,25(OH) 2 D 3 (1,25D), and calcium act in concert to maintain calcium homeostasis by their actions on the kidney, bone, and intestine. There are welldefined negative feedback loops regulating calcium homeostasis. For instance, PTH and 1,25D are both calciotrophic and PTH increases the renal synthesis of 1,25D. 1,25D and calcium both act independently to decrease PTH expression as well as the proliferation of the parathyroid cells (23, 31) . The parathyroid is extremely sensitive to the effect of 1,25D, as small doses of 1,25D markedly decrease PTH mRNA and serum PTH levels in rats and decrease serum PTH in humans (29, 30) . This effect of 1,25D on the parathyroid is used clinically to treat patients with secondary hyperparathyroidism mainly resulting from chronic kidney disease, but also patients with rarer causes of secondary hyperparathyroidism such as X-linked hypophosphatemia (7, 8) .
1,25D increases expression of the calcium receptor (CaR) in the parathyroid (5) both in vivo and in vitro (6) . The CaR is the major regulator of PTH expression and parathyroid cell proliferation (3) . Inactivating mutations or deletion of the CaR are lethal both to mice and humans due to refractory hyperparathyroidism (27) . The CaR Ϫ/Ϫ mice can only be rescued if there is also deletion of the PTH gene or the Gcm2 gene (15, 34) . Deletion of the CaR G protein-coupled receptor (GPCR)-associated G q/11 specifically in the parathyroid also effectively removed the restraining action of the CaR on the parathyroid and these mice developed severe hyperparathryoidism and the condition was lethal (36) .
1,25D binds to the vitamin D receptor (VDR) which heterodimerizes with the retinoid X receptor (RXR) and interacts with a vitamin D-responsive element (VDRE) in the promoter region of its target genes (26) . 1,25D acts on the VDR in the parathyroid to increase the expression of the VDR which then amplifies its effect to decrease PTH gene transcription (22, 30) . 1,25D transrepresses gene transcription of PTH and the renal 25(OH)D 1␣(OH)ase (13, 21) . The transrepression of the PTH gene has been shown in vivo and in vitro using primary cultures of bovine parathyroid cells and in heterologous cell lines (14, 30, 31) .
Total body VDR null (VDR Ϫ/Ϫ ) mice have severe hypocalcemia and secondary hyperparathyroidism, and a rescue diet containing 2% calcium and 20% lactose corrected the hypocalcemia and accompanying secondary hyperparathyroidism at 90 days (16, 35) . In contrast, the rescue was incomplete in another study with VDR Ϫ/Ϫ mice (32) . These studies using calcium rescue diets were indirect approaches to determine the role of the VDR in normal parathyroid physiology. To answer this question directly, we generated mice with the VDR gene specifically deleted in the parathyroid (PT-VDR Ϫ/Ϫ ) by Crelox recombination.
MATERIALS AND METHODS

Animals. Parathyroid-specific VDR null (PT-VDR
Ϫ/Ϫ ) mice were obtained by crossing floxed VDR (VDR lox ) mice (35) with PTH-Cre mice (18) . The total body VDR null (VDR Ϫ/Ϫ ) mice were generated by crossing VDR lox mice with phosphoglycerate-kinase-Cre mice where Cre is expressed throughout the body (35) . All animal experiments were approved by the Hadassah Hebrew University Animal Care and Use Committee.
Screening of transgenic mice. Genomic DNA was isolated from mouse tail tips and analyzed by PCR. Genomic DNA from thyroparathyroid glands was isolated from paraffin sections as described (28) . For the detection of wild-type (wt) and floxed VDR, PCR was performed using three primers: VDR-4flF (5Ј-TTTGGCCTTTCT-GCTTGCCTCTTC-3Ј) and VDR-3flR (5Ј-AGCGACACTCTTGGT-CTGGTTCC-3Ј), surrounding an intron fragment that was lost by introducing the lox cassette into the genomic VDR DNA, and the VDR-4wtR primer (5Ј-GGACCAGGAAAAAAGGGGAGGTG-3Ј) located within this fragment. A PCR product of 320 bp was obtained from wt allele and a fragment of 180 bp from the floxed VDR allele, due to the loss of the intronic fragment. PTH-Cre was identified by PCR using primers PTHCre-F (5Ј-CAGTTGTCTTTAGTTTACTCAGCATCAG-3Ј), located in the PTH promoter, and PTH-Cre-R (5Ј-GATAATCGCGAACATCT-TCAGGTT-3Ј), located in the Cre sequence. Presence of PTH-Cre resulted in a 350-bp PCR product. Detection of deleted VDR allele was performed using the VDR-3flR and VDR-3F primer (5Ј-CACAAC-AGTCAGAGGCAGTAAGCAAAGC-3Ј), located upstream to the 5Ј loxP site (Fig. 1, A and C) . Excision resulted in a 270-bp fragment that was not obtained in the floxed allele in the reaction conditions used (Fig.  1C) . Primers for VDR mRNA RT PCR analyzing exon 2 deletion were located in exon 1 and exon 3: 5Ј-CGCCCCCTGCTCCTTCAG-3Ј and 5Ј-TTGGTGATGCGGCAATCTC-3Ј or in exon 2 and exon 3: 5Ј-GGCTTCCACTTCAACGCTATG-3Ј and 5Ј-GTGATGCGGCAATCTC-CATT-3Ј (Fig. 2B) . cDNA was synthesized with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) and PCR analysis was preformed with GoTaq Green PCR Master Mix (Promega, Madison, WI). Amplicon specificity was ascertained by length evaluation by ethidium bromide staining of agarose gels. PTH mRNA levels were analyzed by real-time qRT PCR using ABI Prism 7900 Sequence Detection System (Applied Biosystems) and SYBR Green Mix (Applied Biosystems). The primers for PTH mRNA were 5Ј-ATGGGAAACCCGTGAGGAAG-3Ј and 5Ј-CATTGCATC-CTCTCCATGGA-3Ј.
Tissue samples and analysis. Thyroparathyroid tissue was excised and fixed in 4% formaldehyde, embedded in paraffin, and cut into 4-m sections. Immunostaining was performed using the following primary antibodies diluted in Cas-block (ZYMED): VDR (Santa Cruz Biotechnology, Santa Cruz, CA; sc-1009) diluted 1:100, PTH (Abd Serotec, Oxford, UK; 7170-6216) diluted 1:100, Ki-67 (Biocare Medical, Concord, CA; CM137A) diluted 1:100, and CaR (Novus Biologicals, Littleton, CO; NB120-19347) at a concentration of 2 g/ml. Slides were incubated with the appropriate horseradish peroxidase-conjugated secondary antibodies and stained by exposure to DAB-chromogen (DAKO, Carpinteria, CA) followed by counterstaining with hematoxylin. Immunostaining was quantified by Ariol system (Applied Imaging, New Milton, UK). For each analysis, three to eight different specimens were quantified.
Parathyroid tissue recovery by laser capture microdissection and RNA extraction. The parathyroids from formalin-fixed, paraffin-embedded mouse thyroparathyroid sections were laser microdissected using a PALM Microlaser System (Zeiss, Munich, Germany). RNA was extracted using peqGold TriFast (Peqlabs biotechnologie GmBH, Erlangen, Germany) supplemented with glycogen. cDNA was synthesized with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and PCR analysis was preformed with GoTaq Green PCR Master Mix (Promega). Amplicon specificity was ascertained by length evaluation by ethidium bromide staining of agarose gels.
Calcium-PTH relationship. Five VDR ϩ/ϩ mice and five PT-VDR Ϫ/Ϫ mice were injected intraperitoneally (ip) with calciumgluconate (300 mol/kg) or EGTA (450 mol/kg) dissolved in sterile saline (12) . Blood samples were collected from tail vein for serum PTH and calcium measurements.
Serum biochemistry. PTH was measured using a mouse intact PTH ELISA kit (Immutopics, San Clemente, CA). Total calcium was measured using QuantiChrom Calcium assay kit (BioAssay Systems, Hayward, CA). 1,25(OH) 2D3 was measured by RIA kit (Diasorin, Stillwater, MN). Serum CTX and osteocalcin levels were determined by ELISA (Ratlaps, Nordic Bioscience Diagnosis A/S) and an inhouse RIA [Verhaeghe, Endocrinology, 1989 (143-151)], respectively.
Statistics. Numerical data are presented as means Ϯ SE. Baseline weight and serum biochemistry in VDR ϩ/ϩ and PT-VDR Ϫ/Ϫ mice were compared by independent samples t-test. In all analyses, twosided P values Ͻ0.05 were considered statistically significant.
RESULTS
Generation of the parathyroid-specific VDR gene deletion.
We deleted the VDR specifically in the mouse parathyroid using the Cre/loxP recombination system. Floxed VDR (VDR lox/lox ) mice (19, 35) were intercrossed with transgenic mice in which Cre recombinase was driven by the PTH promoter (PTH-Cre) (18) to produce mice with parathyroid-specific VDR gene deletion (PT-VDR Ϫ/Ϫ ; Fig. 1 , A-C). Genotyping was performed by PCR analysis of genomic tail and parathyroid DNA to identify VDR lox/lox , PTH-Cre (not shown), and the 270-bp fragment resulting after deletion of exon 2 (Fig. 1D) . Mice that expressed the VDR lox/lox throughout the body but not the Cre allele were used as control (VDR ϩ/ϩ ; Fig. 1D ). Mice with the VDR deletion specifically in the parathyroid (PT-VDR Ϫ/Ϫ ) expressed the VDR lox/lox , PTH-Cre alleles throughout the body (not shown) and the deleted allele only in the parathyroid and not in tail DNA (Fig. 1D) . We also generated total body VDR Ϫ/Ϫ mice by crossing VDR lox/lox mice with the phosphoglycerate-kinase-Cre mice where Cre is expressed throughout the body (35) . These mice expressed the deleted allele in both tail and parathyroid DNA (Fig. 1D) .
We then studied the expression of the VDR mRNA in the parathyroid of the knockout mice. Because of the minute size of the mouse parathyroid, we isolated parathyroid tissue by laser capture microdissection of paraffin-embedded thyroparathyroid blocks (Fig. 2A) . The extracted RNA was analyzed using primers localized in exons 1 and 3 or exons 2 and 3 to distinguish between mRNA from VDR ϩ/ϩ , PT-VDR Ϫ/Ϫ , and VDR Ϫ/Ϫ mice (Fig. 2B ). RT-PCR using primers localized in exons 1 and 3 resulted in a larger PCR product which included exon 2 in the VDR ϩ/ϩ cDNA and a smaller product indicating deletion of exon 2 in the PT-VDR Ϫ/Ϫ and the total body VDR Ϫ/Ϫ mice (Fig. 2C, left) . Similarly, RT-PCR using primers localized in exons 2 and 3 ( Fig. 2B ) resulted in the expected PCR product with cDNA from VDR ϩ/ϩ mice and no products with parathyroid cDNA from total body and parathyroid VDR knockout mice (Fig. 2C, right) . Thus, exon 2 was deleted in the VDR mRNA in parathyroids of both the PT-VDR Ϫ/Ϫ and the total body VDR Ϫ/Ϫ mice but not in VDR ϩ/ϩ mice. We then measured PTH mRNA levels in the laser-captured parathyroid RNA of the different mice. PTH mRNA was increased in the total body VDR Ϫ/Ϫ mice compared with control mice (VDR ϩ/ϩ ). Remarkably, there was no change in the PTH mRNA levels in the PT-VDR Ϫ/Ϫ mice (Fig. 2D) .
Expression of VDR, PTH, CaR, and Ki67 in the parathyroids of PT-VDR
Ϫ/Ϫ mice. We examined thyroparathyroid sections by immunohistochemistry (IH) and its quantification. VDR staining in the parathyroids of PT-VDR Ϫ/Ϫ mice was markedly decreased compared with VDR ϩ/ϩ mice and similar to the decreased VDR staining in total body VDR Ϫ/Ϫ mice (Fig. 3 , A top row and B). It should be noted that deletion of exon 2 results in a truncated form of the VDR (4) (Fig. 3, A row 2 and B) . This is in contrast to the high-serum PTH levels (35) and PTH mRNA levels (Fig. 2D) in the VDR Ϫ/Ϫ mice. In the PT-VDR Ϫ/Ϫ mice, there were moderately increased serum PTH levels (Table 1) and no change in PTH mRNA (Fig. 2D) . CaR levels were decreased in the PT-VDR Ϫ/Ϫ and VDR Ϫ/Ϫ mice (Fig. 3, A row  3 and B) . Ki67 staining, a marker of cell proliferation, was as expected increased in mice with systemic deletion of the VDR gene (VDR Ϫ/Ϫ ) (17), but was not significantly altered in the PT-VDR Ϫ/Ϫ mice compared with VDR ϩ/ϩ mice (Fig. 3 , A row 4 and C). These data suggest that a reduction in VDR levels in the parathyroid decreases the expression of the CaR but does not increase parathyroid cell proliferation.
Biochemical characterization of the PT-VDR Ϫ/Ϫ mice. The body weight and serum calcium levels were comparable between PT-VDR Ϫ/Ϫ and VDR ϩ/ϩ mice ( Table 1 ). The total body VDR Ϫ/Ϫ mice exhibit marked hypocalcemia as previously reported (GC and RB) reflecting decreased intestinal calcium absorption (35) . Serum Pi and 1,25D were the same in the PT-VDR Ϫ/Ϫ and VDR ϩ/ϩ mice ( Table 1) . The normal 1,25D levels in the PT-VDR Ϫ/Ϫ mice are in contrast to the marked increase in 1,25D levels in the total body VDR Ϫ/Ϫ mice ( Table  1) . Serum PTH levels were significantly increased in the PT-VDR Ϫ/Ϫ mice ( Table 1 ), suggesting that the VDR regulates basal serum PTH levels. However, this 20% increase in serum PTH is far less than the 10-fold increase in serum PTH reported in the total body VDR Ϫ/Ϫ mice (35) . We then measured the effect of changes in serum calcium on serum PTH.
The serum calcium of the VDR ϩ/ϩ and PT-VDR Ϫ/Ϫ mice was either decreased by ip injection of EGTA or increased by ip injection of calcium gluconate and then serum PTH and calcium were measured (12) . There was no change in the sensitivity of the parathyroid glands of the PT-VDR Ϫ/Ϫ mice as determined by the changes in serum PTH after alterations in serum calcium (Fig. 4) . Therefore, despite the parathyroid VDR gene deletion and the decreased CaR, the parathyroids retained their sensitivity to changes in serum calcium.
Markers of the end-organ effects of PTH in the PT-VDR
Ϫ/Ϫ mice. To study the biological effect of the increased PTH levels in the PT-VDR Ϫ/Ϫ mice on bone, we measured serum Cterminal collagen crosslinks (CTX), a marker of bone resorption, and serum osteocalcin, the osteoblast marker. CTX was increased in the PT-VDR Ϫ/Ϫ mice compared with VDR ϩ/ϩ , with no change in serum osteocalcin, consistent with a resorptive effect of the increased serum PTH levels in the PT-VDR Ϫ/Ϫ mice (Fig. 5, A-B) .
DISCUSSION
We deleted the VDR specifically in the parathyroid. VDR deletion in the parathyroids of the PT-VDR Ϫ/Ϫ mice was demonstrated both by IH and mRNA in laser-captured tissues. The VDR antibody used here detects the NH 2 -terminal epitope. Deletion of exon 2 that includes the AUG codon for the first methionine results in a truncated form of the VDR (4) which reduces the affinity of the antibody for the VDR but does not totally eliminate immunostaining. This residual staining can be seen in both PT-VDR Ϫ/Ϫ mice and total body VDR Ϫ/Ϫ mice (Fig. 3) . To show that exon 2 is deleted in the VDR mRNA, we performed RT-PCR of laser-captured parathyroid tissue, which confirmed deletion of the second exon in the parathyroids of the PT-VDR Ϫ/Ϫ and total body VDR Ϫ/Ϫ mice. This deletion would lead to a truncated nonfunctional VDR protein (4).
1,25D increases transcription and expression of the parathyroid CaR (5, 6). Accordingly, the CaR is decreased in the parathyroid in secondary hyperparathyroidism of renal failure where 1,25D levels are decreased (37) . IH analysis of the parathyroid glands of the knockout mice showed decreased CaR in both the parathyroid-specific and total body VDR Ϫ/Ϫ mice. The decreased CaR reported here may in part reflect the absence of the stimulatory effect of vitamin D on CaR expression in the parathyroid. The decreased CaR in the parathyroids of the PT-VDR Ϫ/Ϫ and total body VDR Ϫ/Ϫ mice would contribute to an increased serum PTH. It is of interest that the CaR was decreased in both total body and parathyroid-specific VDR Ϫ/Ϫ mice but the hyperparathryodisim was far greater in the total body VDR Ϫ/Ϫ mice probably due to the hypocalcemia. The enhanced PTH levels in the PT-VDR Ϫ/Ϫ mice would explain the increase in serum CTX, a bone resorption marker albeit not a very sensitive marker. However, there is no change in the sensitivity of the parathyroid glands of the PT-VDR Ϫ/Ϫ mice to calcium, as measured by the changes in serum PTH after alterations in serum calcium. In addition, neither serum calcium nor parathyroid cell proliferation was affected in this mouse model which makes it difficult to interpret the contribution of the decreased parathyroid CaR content in this model. In mice with overexpression of a dominant negative G␣ q targeted to the parathyroid which would disrupt CaR function, there was a marked increase in serum PTH with no change in serum calcium (25) .
The PT-VDR Ϫ/Ϫ mice differ markedly from the systemic VDR Ϫ/Ϫ mice which show marked hypocalcemia, high serum PTH levels, and parathyroid hyperplasia. However, in the VDR Ϫ/Ϫ mice, it is not possible to separate the effect of hypocalcemia from that of VDR deletion in the parathyroid. Calcium supplementation rescued hypocalcemia and hyperparathyroidism and restored bone mineralization in some of the VDR Ϫ/Ϫ mice strains and in patients with loss of VDR function (1, 2, 16, 35) . These findings suggest that calcium is the main factor involved in the systemic effects of the lack of VDR function (16) . However, the VDR has specific effects at least on hair follicle function where calcium correction does not prevent the alopecia in VDR knockout mice (16) . In vitro studies revealed that osteoblasts lacking VDR demonstrate enhanced differentiation potential (33) . In addition, growth plate abnormalities in mice lacking VDR were observed before the onset of hypocalcemia, suggesting a defined role for VDR in endochondral bone formation (17) . A further role for the VDR in chondrocytes is its ability to promote osteoclastogenesis and regulate FGF23 production in osteoblasts (19) . Despite the increased serum PTH in the PT-VDR Ϫ/Ϫ mice, there was in fact a decrease in parathyroid PTH content as measured by IH (Fig. 3, A-B) . This decrease in PTH was also evident in the VDR Ϫ/Ϫ mice where serum PTH levels were even higher (35) . Our results demonstrate that the increased serum PTH levels in both models are accompanied by depletion of hormone stores. In fact, there are limited stores of PTH consistent with the observation that the number of granules in the parathyroid is small compared with those in other endocrine glands (10) . After the stimulus of hypocalcemia, hormone stores are depleted after a few hours (20) emphasizing the important role of increased PTH gene expression, synthesis, and cell proliferation in situations of hyperparathyroidism, either primary or secondary (29) . Active secretion is often accompanied by a decrease in hormonal content in other endocrine systems (9, 11) . It is of interest that the decreased PTH by IH was equivalent in the parathyroid-specific and total VDR knockout mice despite the far higher serum PTH levels in the VDR Ϫ/Ϫ mice. PTH mRNA levels as measured in lasercaptured parathyroid tissue were increased in the VDR Ϫ/Ϫ mice but not in the PT-VDR Ϫ/Ϫ mice. This suggests that in the VDR Ϫ/Ϫ mice, the increase in gene expression and cell number is a major factor contributing to the higher serum PTH levels. In the PT-VDR Ϫ/Ϫ mice, the moderate increase in serum PTH with no increase in PTH mRNA and parathyroid cell proliferation indicates a minor role for the VDR in parathyroid physiology.
Deletion of the VDR specifically in the parathyroid allows us to define the particular effects of the VDR in the parathyroid and separate them from the effects of vitamin D on its other target organs. Our findings suggest that in mice with increased serum PTH, there are adaptive mechanisms which maintain a normal serum calcium. The finding that the PT-VDR Ϫ/Ϫ mice do not have the increased parathyroid cell proliferation of the VDR Ϫ/Ϫ mice suggests that VDR depletion itself is not the cause of parathyroid hyperplasia. The VDR Ϫ/Ϫ mice exhibit marked hypocalcemia which is the predominant factor causing parathyroid cell proliferation in this model. This is consistent with our previous studies in rats where we showed that hypocalcemia leads to marked parathyroid cell proliferation despite high levels of 1,25D (23) . Parathyroid hypertrophy, increased PTH translation, or decrease in PTH degradation that were not measured here may contribute to the moderately increased serum PTH levels in the PT-VDR Ϫ/Ϫ mice. The moderate increase in serum PTH after parathyroid-specific deletion of the VDR is in contrast to the well-established effect of administered calcitriol and its analogs to decrease serum PTH in animals or humans even in the absence of hypercalcemia and/or hyperphosphatemia. The contribution of a putative unidentified membrane VDR cannot be ruled out (24) .
In summary, we generated mice with the VDR gene deleted specifically in the parathyroid. These mice demonstrate that the VDR sets the basal levels of serum PTH and CaR expression in the parathyroid. The decreased CaR expression may result in less suppression of PTH excretion and hence increased serum PTH. The CaR in the PT-VDR Ϫ/Ϫ mice, however, still responds to changes in serum calcium resulting in an intact relationship between calcium and PTH. Despite the dramatic effect of 1,25D and its analogs to decrease PTH expression, the effect of specific deletion of the VDR in the parathyroid has only a moderate effect on parathyroid function which may be largely due to the decrease in parathyroid CaR expression.
